Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -18.56% |
| 2023 | 14.92% |
| 2022 | 63.77% |
| 2021 | 39.38% |
| 2020 | -7.35% |
| 2019 | 69.41% |
| 2018 | 80.83% |
| 2017 | 202.18% |
| 2016 | -67.35% |
| 2015 | -8.45% |